Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ: AUPH · Real-Time Price · USD
8.09
+0.10 (1.19%)
At close: Jun 5, 2025, 4:00 PM
8.09
0.00 (0.06%)
After-hours: Jun 5, 2025, 4:00 PM EDT

Aurinia Pharmaceuticals Stock Forecast

Stock Price Forecast

According to 2 professional analysts, the 12-month price target for Aurinia Pharmaceuticals stock ranges from a low of $10 to a high of $13. The average analyst price target of $11.5 forecasts a 42.24% increase in the stock price over the next year.

Price Target: $11.50 (+42.24%)
Analyst Consensus: Strong Buy
Target Low Average Median High
Price $10 $11.5 $13 $13
Change +23.69% +42.24% +60.79% +60.79%
* Price targets were last updated on Sep 16, 2024.

Analyst Ratings

The average analyst rating for Aurinia Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Dec '24Jan '25Feb '25Mar '25Apr '25May '25
Strong Buy 111111
Buy 222221
Hold 000000
Sell 000000
Strong Sell 000000
Total 333332

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Reiterates
$10
Buy Reiterates $10 +23.69% Sep 16, 2024
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Reiterates
$10
Buy Reiterates $10 +23.69% Sep 9, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$13
Strong Buy Reiterates $13 +60.79% Sep 6, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$13
Strong Buy Reiterates $13 +60.79% Mar 1, 2024
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Maintains
$12$10
Buy Maintains $12$10 +23.69% Feb 23, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
263.69M
from 235.13M
Increased by 12.15%
Revenue Next Year
311.96M
from 263.69M
Increased by 18.31%
EPS This Year
0.61
from 0.04
Increased by 1,430.00%
EPS Next Year
0.79
from 0.61
Increased by 29.67%
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
50.12M45.61M134.03M175.51M235.13M263.69M311.96M371.83M
Revenue Growth
15,660.38%-9.01%193.89%30.95%33.97%12.15%18.31%19.19%
EPS
-0.87-1.40-0.76-0.540.040.610.791.12
EPS Growth
-----1,430.00%29.67%40.96%
Forward PE
-----13.2110.197.23
No. Analysts
-----775
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026202720282029
High 273.0M 373.6M 469.0M
Avg 263.7M 312.0M 371.8M
Low 251.1M 284.2M 313.6M

Revenue Growth

Revenue Growth 20252026202720282029
High
16.1%
41.7%
50.3%
Avg
12.1%
18.3%
19.2%
Low
6.8%
7.8%
0.5%

EPS Forecast

EPS 20252026202720282029
High 0.80 1.40 1.82
Avg 0.61 0.79 1.12
Low 0.44 0.53 0.69

EPS Growth

EPS Growth 20252026202720282029
High
1,895.0%
128.2%
128.9%
Avg
1,430.0%
29.7%
41.0%
Low
1,002.5%
-13.5%
-13.6%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.